Thermo Fisher opens Bioprocess Design Center in Hyderabad
Expands bioprocessing footprint across Asia
Expands bioprocessing footprint across Asia
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
Adverse events were similar to placebo, and no AP-101-induced antibody responses were detected
While Merck can appeal, Halozyme said it expects the order to hold
Freenome expects the combined company to receive approximately $330 million in proceeds at closing
DUPLEX’s two-compartment, PVC- and DEHP-free design keeps medication and diluent separate until activation
It's an acquisition that aims at forming one of the US's largest oncology trial networks
Peapod Bio’s proprietary technologies can efficiently identify inhibitors and binding molecules for virtually any target
The center will offer training to super-specialist doctors and healthcare professionals in various fields
Subscribe To Our Newsletter & Stay Updated